$IBB News Value trumps growth as investors pick Exxon

New Post Public Reply Private Reply Replies (0) Message Board

Apr 29, 2014 at 12:34 PM

$IBB News

Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. Today - William L. Watts
Buy low (tech), sell high (tech) 4:46 p.m. April 28, 2014 - Bill Donoghue
Dow, S&P 500 swing back to positive territory: Stock market live blog recap 4:11 p.m. April 28, 2014 - blogs.marketwatch.com
Internet, social-media ETFs hit new 2014 lows; biotech fares a bit better 3:45 p.m. April 28, 2014 - blogs.marketwatch.com
Tech leads slide as stocks erase their weekly gains: Stock market live blog recap 4:31 p.m. April 25, 2014 - blogs.marketwatch.com
Stocks are moving on share buybacks, splits 6:01 a.m. April 25, 2014 - Dave Fry
S&P 500, Nasdaq end 6-day win streak: Stock market live blog recap 4:09 p.m. April 23, 2014 - blogs.marketwatch.com
Dow industrials hesitate at major resistance 11:22 a.m. April 23, 2014 - Michael Ashbaugh
Gilead shares climb; AT&T, Amgen shares fall 5:55 p.m. April 22, 2014 - Myra P. Saefong
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Nasdaq biotech ETF 'IBB' shares rise 1% after hours 4:25 p.m. April 22, 2014 - Laura Mandaro
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
S&P 500 achieves best weekly gain since July: stock market live blog recap 3:48 p.m. April 17, 2014 - blogs.marketwatch.com
4 reasons the first quarter was better than it appeared 6:20 a.m. April 17, 2014 - Tim Clift
Biotech starts recovery as ETFs finish day firmly in the black 5:23 p.m. April 16, 2014 - blogs.marketwatch.com
S&P 500 positive for year as stocks rise for 3rd day in row: stock market live blog recap 4:14 p.m. April 16, 2014 - blogs.marketwatch.com
Tech plays try to find a bottom, with key biotech, Internet ETFs all up this week 11:46 a.m. April 16, 2014 - blogs.marketwatch.com
Stocks gain for 2nd day in row after Ukraine fears ease 4:33 p.m. April 15, 2014 - Victor Reklaitis
IShares Nasdaq biotech ETF turns positive, up 1% 3:39 p.m. April 15, 2014 - Russ Britt
Biotech ETFs, shares can't make up their minds on a choppy trading day 2:51 p.m. April 15, 2014 - blogs.marketwatch.com

'Fast Money' Recap: The Problem With Growth Stocks 5:00 a.m. Today - TheStreet.com
Increase Your Cash Position in This Fatigued Market 9:56 p.m. April 28, 2014 - InvestorPlace.com
Small caps, momo names back in penalty box 1:20 p.m. April 28, 2014 - Seeking Alpha
Pharma ETFs: A Safe Haven from the Biotech Stock Slump? - ETF News And Commentary 11:42 a.m. April 28, 2014 - Zacks.com
If You Want GARP, Look Into Biotech, Not Utilities, But Do The Valuations 11:35 a.m. April 28, 2014 - Seeking Alpha
Don’t Bet on a Bottom Being Put in Here 2:57 a.m. April 28, 2014 - InvestorPlace.com
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. April 26, 2014 - 247WallSt.com
Networked hospital gear vulnerable to hacking 2:49 p.m. April 25, 2014 - Seeking Alpha
Sharp losses for small caps and tech; money flows into utilities 1:31 p.m. April 25, 2014 - Seeking Alpha
Scientists decipher the genome of one of world's most despised pests 12:46 p.m. April 25, 2014 - Seeking Alpha
Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary 8:00 a.m. April 24, 2014 - Zacks.com
What a Wild Ride It's Been 6:35 a.m. April 24, 2014 - RealMoney.com
Will Today Be the Day the Dow Finally Does It? 9:11 p.m. April 23, 2014 - InvestorPlace.com
ETF Risk And Reward Tradeoffs Today - What Will They Be Tomorrow Or Next Month? 7:34 p.m. April 23, 2014 - Seeking Alpha
Pharma ETFs: A Better Healthcare Investment? - Video Blog 6:42 p.m. April 23, 2014 - Zacks.com
4 Stocks to Sell Into Pressure (And 1 to Buy) 10:58 a.m. April 23, 2014 - InvestorPlace.com
Harvard Apparatus Regenerative Technology; A Strategic Plan To Profitability 8:18 a.m. April 23, 2014 - Seeking Alpha
The Trader Daily 7:30 a.m. April 23, 2014 - RealMoney.com
Medical devices set to join the accelerated review club 11:33 a.m. April 22, 2014 - Seeking Alpha
Trade of the Day: Target (TGT) 4:10 a.m. April 22, 2014 - InvestorPlace.com

OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 8:43 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New JPA Aims to Energize Inland Empire's Water Supply

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

PrePass Intelligence: A Game-Changer for Fleets

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Costa Rican Firms Chase Growth at SIAL Paris 2026

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Meitav Tops 2025 Service Index with Stellar Growth

Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...

Standex's New Financial Lead: Stoddard Takes Helm

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

QFIN Faces Class Action: Investors' Role Explored

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Zika Virus: A Surprising Ally in Brain Cancer Fight

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

F.N.B. Q3 2026 Earnings: Solid Growth Continues

F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...